Answers are grounded in this paper and cite their sources.
Previous studies link the Dietary Index for Gut Microbiota (DI-GM) to mortality in CKM syndrome, but its robustness and added prognostic value remain unclear. We included 13,286 adults (≥ 20 years) with CKM syndrome from NHANES 2007–2018. Kaplan–Meier curves, weighted Cox regression, restricted cubic splines, subgroup analyses, and sensitivity analyses evaluated associations of DI-GM with all-cause and cardiovascular mortality. Weighted machine-learning analyses further compared DI-GM with the Healthy Eating Index-2015 (HEI-2015), Dietary Approaches to Stop Hypertension (DASH), and Dietary Inflammatory Index (DII), and assessed the relative prognostic contributions of its 14 components. During a median follow-up of 80 months, 1,207 all-cause deaths occurred, including 368 cardiovascular deaths. Each 1-SD increase in DI-GM was associated with 11% and 17% lower risks of all-cause and cardiovascular mortality, respectively (HR = 0.89, 95% CI 0.83–0.95, P < 0.001; HR = 0.83, 95% CI 0.74–0.94, P = 0.003). RCS analyses showed linear inverse associations; significant interactions by age and CKM stage were observed for cardiovascular mortality; and sensitivity analyses supported robustness. DI-GM demonstrated prognostic discrimination comparable to established dietary indices. Component-level analyses revealed the contributions of specific dietary components. DI-GM offers a complementary gut microbiota-based perspective for prognosis and dietary management in CKM syndrome.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: